Abstract
Triggering of Fas (CD95) by its ligand (FasL) rapidly induces cell death via recruitment of the adaptor protein Fas-associated death domain (FADD), resulting in activation of a caspase cascade. It was thus surprising that T lymphocytes deficient in FADD were reported recently to be not only resistant to FasL-mediated apoptosis, but also defective in their proliferative capacity. This finding suggested potentially dual roles of cell growth and death for Fas and possibly other death receptors. We report here that CD3-induced proliferation and interleukin 2 production by human T cells are blocked by inhibitors of caspase activity. This is paralleled by rapid cleavage of caspase-8 after CD3 stimulation, but no detectable processing of caspase-3 during the same interval. The caspase contribution to T cell activation may occur via TCR-mediated upregulation of FasL, as Fas-Fc blocked T cell proliferation, whereas soluble FasL augmented CD3-induced proliferation. These findings extend the role of death receptors to the promotion of T cell growth in a caspase-dependent manner.
MeSH Terms
CD3 Complex/immunology
Caspases/immunology
Cell Division/immunology
Enzyme Activation/immunology
Fas Ligand Protein
Humans
Lymphocyte Activation
Membrane Glycoproteins/immunology
Signal Transduction/immunology
T-Lymphocytes/cytology,immunology
fas Receptor/immunology
Chemicals
CD3 Complex
FASLG protein, human
Fas Ligand Protein
Membrane Glycoproteins
fas Receptor
Caspases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Kennedy N J
Immunobiology Program, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405, USA.
Kataoka T
Tschopp J
Budd R C
References (15)
15 references, click to expand
-
FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis.
Science. 1998 Mar 20;279(5358):1954-8
PMID: 9506948
-
Newly discovered role for Fas ligand in the cell-cycle arrest of CD4+ T cells.
Nat Med. 1998 Dec;4(12):1377-82
PMID: 9846574
-
Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.
J Exp Med. 1998 Apr 20;187(8):1205-13
PMID: 9547332
-
Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
Nature. 1998 Mar 19;392(6673):296-300
PMID: 9521326
-
Activation interferes with the APO-1 pathway in mature human T cells.
Int Immunol. 1993 Jun;5(6):625-30
PMID: 7688561
-
Fas transduces activation signals in normal human T lymphocytes.
J Exp Med. 1993 Dec 1;178(6):2231-5
PMID: 7504062
-
T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A.
Eur J Immunol. 1994 Oct;24(10):2469-76
PMID: 7523141
-
The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice.
Immunity. 1994 Aug;1(5):365-71
PMID: 7533645
-
Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor.
FEBS Lett. 1995 May 1;364(1):5-8
PMID: 7538467
-
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
EMBO J. 1995 Nov 15;14(22):5579-88
PMID: 8521815
-
Apoptosis by death factor.
Cell. 1997 Feb 7;88(3):355-65
PMID: 9039262
-
Inhibition of death receptor signals by cellular FLIP.
Nature. 1997 Jul 10;388(6638):190-5
PMID: 9217161
-
A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes.
EMBO J. 1998 Feb 2;17(3):706-18
PMID: 9450996
-
A role for FADD in T cell activation and development.
Immunity. 1998 Apr;8(4):439-49
PMID: 9586634
-
Death receptors: signaling and modulation.
Science. 1998 Aug 28;281(5381):1305-8
PMID: 9721089